Company Filing History:
3 out of 621 
3 out of 1,719 
1 out of 4 Years Active: 2006-2015
I specialize in innovations, inventions, inventors, patent attorneys, assignees and patents.
Title: Innovator Spotlight: Wen-Mei Fu - Revolutionizing Eye Disease Treatments
Introduction: Wen-Mei Fu, a renowned inventor hailing from Taipei, TW, has made significant contributions to the field of medical science with a total of 6 patents to his name. His groundbreaking work has focused on developing cutting-edge compositions and methods for the treatment of angiogenesis-related eye diseases.
Latest Patents:
1. "Compositions and methods for the treatment of angiogenesis-related eye diseases": Involving the use of low doses of rhodostomin variants fused with a variant of Human Serum Albumin, this patent addresses the effective treatment and prevention of angiogenesis-related eye diseases.
2. "Methods of treating αvβ3 integrin-associated diseases by administering polypeptides selective for αvβ3 integrin": This patent introduces disintegrin variants as selective αvβ3 integrin antagonists for the treatment and prevention of associated diseases, offering a novel approach to medical intervention.
Career Highlights: Wen-Mei Fu has made significant strides in his career, notably through his employment at prestigious institutions such as National Cheng-kung University and National Taiwan University. His dedication to innovation and commitment to advancing medical research have been the hallmarks of his professional journey.
Collaborations: Throughout his career, Wen-Mei Fu has collaborated with esteemed colleagues such as Woei-Jer Chuang and Chih-Hsin Tang. These partnerships have led to the development of groundbreaking solutions that have the potential to revolutionize the field of medical science.
Conclusion: Wen-Mei Fu's innovative work in developing advanced treatments for angiogenesis-related eye diseases underscores his status as a pioneering figure in the field of medical research. His patents stand as a testament to his unwavering commitment to improving healthcare outcomes and changing the landscape of modern medicine.